Still do not see any specific rates,those are all estimates taken from a consensus of the people paying the rates to the companies.Where has a specific company given the rate they charge others?I would bet it is highly uncommon for a company to publically disclose that, the numbers probably leak out eventually though from the company paying the license fee." Up to 15%" and "15 % or more" are not specifics.

It is not a bad question to ask, but to make the leap that no shareholders will profit from the sale of Dharmanol is ridiculous.Why would DGold and BBio be shareholders in that venture?Why give away their lifes work?Please explain to me how BBio benefits if the shares do not benefit?Makes zero sense to me.

So show me a press release from any company giving specific license rates,like those you are asking Sk3 to disclose, and I will be satisfied.
The more obvious answer is they have not sold enough Dharmanol to reach the bottom line.
All of us would like answers to what do shareholders get when Yak products are sold in collectives,it is not a bad question,I just question the conclusions you leap to.